ConductScience.org, home

Paper26344625

Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus.

Schwartz EJ and 1 other. Vaccines (Basel), 2014. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus. Papers, record 26344625. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26344625

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus.
PubMed
Journal
Vaccines (Basel)
PubMed
Year
2014
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.23
iCite
Revised in PubMed
2023-11-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schwartz EJElissa J
2Smith RJRobert J

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115838802Predicting the potential individual- and population-level effects of imperfect herpes simplex virus type 2 vaccines.J Infect Dis2005https://conductscience.org/library/papers/15838802PubMed
29143283Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.Virology1997https://conductscience.org/library/papers/9143283PubMed
324252283Understanding virus-host dynamics following EIAV infection in SCID horses.J Theor Biol2014https://conductscience.org/library/papers/24252283PubMed
419368787Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.Vaccine2009https://conductscience.org/library/papers/19368787PubMed
521865397Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection.J Virol2011https://conductscience.org/library/papers/21865397PubMed
614627745Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/14627745PubMed
821543497Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.J Virol2011https://conductscience.org/library/papers/21543497PubMed
920392850Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.J Virol2010https://conductscience.org/library/papers/20392850PubMed
1015236678Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?Vet Res2004https://conductscience.org/library/papers/15236678PubMed
1110196297Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.J Virol1999https://conductscience.org/library/papers/10196297PubMed
1211683583Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses.Clin Immunol2001https://conductscience.org/library/papers/11683583PubMed
1320064271Modelling imperfect adherence to HIV induction therapy.BMC Infect Dis2010https://conductscience.org/library/papers/20064271PubMed
1410577640Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis.Lancet1999https://conductscience.org/library/papers/10577640PubMed
1517392785Seasonal dynamics of recurrent epidemics.Nature2007https://conductscience.org/library/papers/17392785PubMed
167541846Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.J Virol1995https://conductscience.org/library/papers/7541846PubMed
1715113912CD8+-cell-mediated suppression of virulent simian immunodeficiency virus during tenofovir treatment.J Virol2004https://conductscience.org/library/papers/15113912PubMed
1818842730
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.
J Virol2008https://conductscience.org/library/papers/18842730PubMed
198265611Pulse mass measles vaccination across age cohorts.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8265611PubMed
2017881889Effectiveness and efficiency of imperfect therapeutic HSV-2 vaccines.Hum Vaccin2007https://conductscience.org/library/papers/17881889PubMed
212839723Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection.J Virol1988https://conductscience.org/library/papers/2839723PubMed

See all 35 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
36992401Key Factors and Parameter Ranges for Immune Control of Equine Infectious Anemia Virus Infection.Viruses2023https://conductscience.org/library/papers/36992401PubMed
34960718Modelling Mutation in Equine Infectious Anemia Virus Infection Suggests a Path to Viral Clearance with Repeated Vaccination.Viruses2021https://conductscience.org/library/papers/34960718PubMed
27287711Characterization of anti-porcine epidemic diarrhea virus neutralizing activity in mammary secretions.Virus Res2016https://conductscience.org/library/papers/27287711PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26344625

GET https://conductscience.org/api/papers/v1/26344625/references?page=2